Post by
Viking2233 on Apr 02, 2024 7:43am
3 more sites
Good newd continues to flow in here. 3 more sites in Turkey now dosing. My best guess the original 3 sites have already dosed about 15 people.
I would suggest that the new sites would not have been added if initial dosing results were negative so I see this as a very bullish sign
We have one site in Calgary coming on line soon, it would be nice to see one of the major heart hospitals in Toronto or Montreal to join the trial.
It has been over two weeks since Arch released data from published British 3rd party peer review from lung data phase 2 trial. Remember Raymond James analyst was waiting 2 years for this yet not a word from this analyst, plus the company has started a new phase 2 AKI study with 6 locations in Turkey and 1 in Canada. We are also now dosing at a much higher strength. We are going to start another phase 2 trial in the fall with a re-purposed drug that is already proven safe. Again no comment from RJ Analyst.
I wonder if this analyst is even covering Arch anymore????